Rodney Barnett White
Examiner (ID: 4089, Phone: (571)272-6863 , Office: P/3636 )
Most Active Art Unit | 3636 |
Art Unit(s) | 3636, 3507, 3624 |
Total Applications | 3742 |
Issued Applications | 3058 |
Pending Applications | 192 |
Abandoned Applications | 490 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17685899
[patent_doc_number] => 20220193191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA
[patent_app_type] => utility
[patent_app_number] => 17/599034
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599034 | LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA | Mar 24, 2020 | Abandoned |
Array
(
[id] => 17593574
[patent_doc_number] => 20220143147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS
[patent_app_type] => utility
[patent_app_number] => 17/440445
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440445
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440445 | INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS | Mar 17, 2020 | Pending |
Array
(
[id] => 17655408
[patent_doc_number] => 20220175873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => SYNTHETIC NEUROMODULATORY PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/437331
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437331 | SYNTHETIC NEUROMODULATORY PEPTIDES | Mar 12, 2020 | Pending |
Array
(
[id] => 16108615
[patent_doc_number] => 20200206330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/815068
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/815068 | PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE | Mar 10, 2020 | Abandoned |
Array
(
[id] => 17671106
[patent_doc_number] => 20220184273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PARTICULATE GEL FOR THE TREATMENT OF A BLEEDING IN THE SINUS OR NASAL CAVITY
[patent_app_type] => utility
[patent_app_number] => 17/436759
[patent_app_country] => US
[patent_app_date] => 2020-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436759 | PARTICULATE GEL FOR THE TREATMENT OF A BLEEDING IN THE SINUS OR NASAL CAVITY | Mar 7, 2020 | Pending |
Array
(
[id] => 17654496
[patent_doc_number] => 20220174961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => FUNCTIONAL PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AGAINST PHYTOPATHOGENIC MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/436853
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436853 | FUNCTIONAL PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AGAINST PHYTOPATHOGENIC MICROORGANISMS | Mar 5, 2020 | Pending |
Array
(
[id] => 17625805
[patent_doc_number] => 20220160820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MODULATORS OF COMPLEMENT ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/437082
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437082 | MODULATORS OF COMPLEMENT ACTIVITY | Mar 5, 2020 | Abandoned |
Array
(
[id] => 17578759
[patent_doc_number] => 20220135614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => SYNTHESIS OF BICYCLE TOXIN CONJUGATES, AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/310781
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310781 | SYNTHESIS OF BICYCLE TOXIN CONJUGATES, AND INTERMEDIATES THEREOF | Mar 2, 2020 | Pending |
Array
(
[id] => 17480643
[patent_doc_number] => 20220088147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN
[patent_app_type] => utility
[patent_app_number] => 17/310993
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310993 | LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN | Mar 2, 2020 | Pending |
Array
(
[id] => 17322585
[patent_doc_number] => 11213572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Cartilage regeneration composition containing HAPLN1 as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/805420
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 4689
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805420 | Cartilage regeneration composition containing HAPLN1 as active ingredient | Feb 27, 2020 | Issued |
Array
(
[id] => 16598074
[patent_doc_number] => 20210024605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => CYCLIC PEPTIDE ANALOGS OF MELANOCORTIN AND AMANITIN AND METHODS OF MAKING SUCH
[patent_app_type] => utility
[patent_app_number] => 16/804465
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804465 | Cyclic peptide analogs of melanocortin and amanitin and methods of making such | Feb 27, 2020 | Issued |
Array
(
[id] => 16695493
[patent_doc_number] => 10946062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Use of recombinant protein for treating metabolic disorders
[patent_app_type] => utility
[patent_app_number] => 16/802171
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2857
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/802171 | Use of recombinant protein for treating metabolic disorders | Feb 25, 2020 | Issued |
Array
(
[id] => 19423766
[patent_doc_number] => 12083157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Use of polylysine dendrimers in the prevention and management of acne-prone skin and acneic skin
[patent_app_type] => utility
[patent_app_number] => 17/441482
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 12522
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441482 | Use of polylysine dendrimers in the prevention and management of acne-prone skin and acneic skin | Feb 20, 2020 | Issued |
Array
(
[id] => 16954914
[patent_doc_number] => 11058742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Food composition for suppressing hepatic lipogenesis
[patent_app_type] => utility
[patent_app_number] => 16/797211
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 32
[patent_no_of_words] => 7456
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797211 | Food composition for suppressing hepatic lipogenesis | Feb 20, 2020 | Issued |
Array
(
[id] => 17460257
[patent_doc_number] => 20220073562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PEPTIDE FOR SKIN AGING PREVENTION AND WRINKLE REDUCTION, AND COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/422494
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422494 | Peptide for skin aging prevention and wrinkle reduction, and composition comprising same | Jan 21, 2020 | Issued |
Array
(
[id] => 17480612
[patent_doc_number] => 20220088116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors
[patent_app_type] => utility
[patent_app_number] => 17/420396
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420396 | Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors | Jan 19, 2020 | Pending |
Array
(
[id] => 17563169
[patent_doc_number] => 20220127318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => RECOMBINANT LUBRICINS, AND COMPOSITIONS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/422736
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422736 | RECOMBINANT LUBRICINS, AND COMPOSITIONS AND METHODS FOR USING THE SAME | Jan 14, 2020 | Pending |
Array
(
[id] => 17563174
[patent_doc_number] => 20220127323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => NOVEL POLYPEPTIDE AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/421297
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421297 | NOVEL POLYPEPTIDE AND THERAPEUTIC USES THEREOF | Jan 6, 2020 | Pending |
Array
(
[id] => 16908069
[patent_doc_number] => 11040086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof
[patent_app_type] => utility
[patent_app_number] => 16/730251
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 2368
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730251 | Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof | Dec 29, 2019 | Issued |
Array
(
[id] => 17480703
[patent_doc_number] => 20220088207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1
[patent_app_type] => utility
[patent_app_number] => 17/416562
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416562 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | Dec 22, 2019 | Pending |